Genmab — Maj 2018
-
Ja slutningen af 18
-
Det undrer mig godt nok købelysten ikke er større i dette niveau. Kan godt være jeg er lidt forblændet, men det ligner godt nok et røverkøb i dette niveau.
-
Selv hvis hele pipelinen failer, retfærdiggør Dara i mm vel en noget højere kurs end den aktuelle. Tager jeg helt fejl eller?
-
-
The note> det vil ud fra FA ikke give mening at den skal ned i 700.
-
fun fact Biotech https://twitter.com/_B_I_O_T_E_C_H_/status/1002258442394963970
-
-
Thanks E L
-
Claus H Johansen is also sending out tweets. He is speculating how much BLUE will fall tomorrow if PFS in bb2121 is only 12 months. We will find out tomorrow, he writes
-
Thanks EL. https://www.ncbi.nlm.nih.gov/pubmed/28544069
-
-
CAR-T til behandling af børn med cancer http://borsen.dk/nyheder/generelt/artikel/1/363611/nyt_center_skal_udvikle_fremtidens_kraeftbehandling_af_boern.html
-
Sjov at de lige nu ændrer til "Recruiting" ? https://clinicaltrials.gov/ct2/show/NCT03184194
-
Claus H Johansen mener iøvrigt at bb2121 præsentationen også er det vigtigste i Genmab kontekst i år på ASCO. Kommer i morgen kl. 5 pm Chicago tid.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind